Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 565.00
+16.80 (3.06%)
At close: Apr 28, 2026
Pharma Aids Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 72.46 | 63.82 | 61.19 | -6.38 | 34.76 | 50.26 | Upgrade
|
| Depreciation & Amortization | 8.29 | 6.5 | 6.92 | 7.62 | 7.82 | 8.25 | Upgrade
|
| Other Operating Activities | -0.75 | -4.9 | -4.82 | -6.51 | -3.69 | -4.8 | Upgrade
|
| Change in Accounts Receivable | -12.26 | -30.73 | 1.63 | -2.54 | 6.21 | 11.85 | Upgrade
|
| Change in Inventory | 37.98 | 10.81 | -17.47 | 6.5 | -15.18 | -27.67 | Upgrade
|
| Change in Accounts Payable | 0.84 | -1.67 | 3.89 | 0.24 | 1.25 | -0.26 | Upgrade
|
| Change in Other Net Operating Assets | -50.62 | -4.07 | -28.55 | 8.33 | 2.67 | -6.22 | Upgrade
|
| Operating Cash Flow | 55.93 | 39.76 | 22.79 | 7.27 | 33.85 | 31.41 | Upgrade
|
| Operating Cash Flow Growth | 772.10% | 74.49% | 213.55% | -78.53% | 7.77% | -22.82% | Upgrade
|
| Capital Expenditures | -56.83 | -57.13 | -0.18 | -2.21 | -4.7 | -10.28 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.55 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Real Estate | -0.32 | -13.53 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.11 | 0.2 | 0.37 | 4.6 | Upgrade
|
| Investing Cash Flow | -57.14 | -70.12 | -0.07 | -2.01 | -4.33 | -5.68 | Upgrade
|
| Short-Term Debt Issued | - | 16.49 | - | 0.49 | 0.68 | - | Upgrade
|
| Total Debt Issued | 16.49 | 16.49 | - | 0.49 | 0.68 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.28 | - | - | -4.78 | Upgrade
|
| Total Debt Repaid | - | - | -0.28 | - | - | -4.78 | Upgrade
|
| Net Debt Issued (Repaid) | 16.49 | 16.49 | -0.28 | 0.49 | 0.68 | -4.78 | Upgrade
|
| Common Dividends Paid | -7.68 | -7.66 | -4.83 | -15.54 | -25.27 | -15.05 | Upgrade
|
| Financing Cash Flow | 8.81 | 8.83 | -5.11 | -15.05 | -24.59 | -19.83 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | 7.6 | -21.53 | 17.61 | -9.79 | 4.93 | 5.89 | Upgrade
|
| Free Cash Flow | -0.89 | -17.37 | 22.6 | 5.06 | 29.15 | 21.12 | Upgrade
|
| Free Cash Flow Growth | - | - | 346.82% | -82.64% | 37.97% | -40.81% | Upgrade
|
| Free Cash Flow Margin | -0.19% | -3.97% | 5.37% | 1.64% | 9.02% | 7.54% | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -5.57 | 7.25 | 1.62 | 9.34 | 6.77 | Upgrade
|
| Cash Interest Paid | 2.44 | 1.75 | 0.26 | 0.24 | 0.24 | 0.9 | Upgrade
|
| Cash Income Tax Paid | 26.92 | 27.15 | 32.43 | 23.71 | 25.15 | 23.17 | Upgrade
|
| Levered Free Cash Flow | 20.22 | -88.26 | 5.59 | 9.86 | 20.13 | 17.39 | Upgrade
|
| Unlevered Free Cash Flow | 21.75 | -87.17 | 5.75 | 10.01 | 20.37 | 17.95 | Upgrade
|
| Change in Working Capital | -24.07 | -25.66 | -40.5 | 12.54 | -5.05 | -22.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.